• $1,241.00
    Market Cap
  • 0.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
09/30/2023
09/30/2022
09/30/2021
09/30/2020
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
77
N/A
Cost of Revenue
1.9M
+47.37%
1.3M
+52,348.80%
2,412
-93.60%
37,682
N/A
Gross Profit
-1.9M
+47.37%
-1.3M
+52,348.80%
-2,412
-93.59%
-37,605
N/A
Sales and Marketing Expense
3,900
-90.94%
43,031
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
0
N/A
0
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
1,275
-4.06%
1,329
N/A
Total Operating Expenses
3.7M
+47.37%
2.5M
+104,797.60%
2,412
-93.60%
37,682
N/A
Operating Profit
-1.9M
+47.37%
-1.3M
-86.09%
-9.1M
+2,894.76%
-303,671
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-91,603
+30.22%
-70,346
-75.53%
-287,499
+20.77%
-238,060
N/A
Interest Income and Expense and Net
-91,603
+30.22%
-70,346
-75.53%
-287,499
+20.77%
-238,060
N/A
Total Nonoperating Income and Expense
-84,879
-61.89%
-222,745
-177.48%
287,499
+20.77%
238,060
N/A
Income before Taxes
-1.9M
+47.37%
-1.3M
-86.09%
-9.1M
+1,578.74%
-541,731
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
37,667
N/A
Net Income
-1.9M
+31.01%
-1.5M
-84.82%
-9.8M
+1,709.32%
-541,731
N/A
Net Income from Continuing Operations Applicable to Common
-1.9M
+31.01%
-1.5M
-84.82%
-9.8M
+1,709.32%
-541,731
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
-0.02
N/A
0.00
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
-0.02
N/A
0.00
N/A
Basic Weighted Average Shares
827.3M
+31.63%
628.5M
+30.38%
482.1M
+61.73%
298.1M
N/A
Diluted Weighted Average Shares
827.3M
+31.63%
628.5M
+30.38%
482.1M
+61.73%
298.1M
N/A
Balance Sheet
Cash and Cash Equivalents
0
-100.00%
6,365
+6.80%
5,960
-92.68%
81,442
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
0
-100.00%
6,365
+6.80%
5,960
-92.68%
81,442
N/A
Total Current Assets
0
-100.00%
9,915
+66.36%
5,960
-93.28%
88,637
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
3,194
+66.44%
1,919
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
1,275
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
1,275
N/A
Total Assets
N/A
N/A
9,915
+66.36%
5,960
-93.37%
89,912
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
59,710
+198.55%
20,000
0.00%
20,000
-87.10%
155,077
N/A
Total Current Liabilities
1.4M
+19.04%
1.2M
+64.60%
731,781
-2.32%
749,134
N/A
Total Long-Term Debt
428,260
+45.17%
295,000
+278.21%
78,000
-77.40%
345,077
N/A
Total Long-Term Liabilities
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
1.4M
+19.04%
1.2M
+64.60%
731,781
-2.32%
749,134
N/A
Retained Earnings
-20.5M
+10.53%
-18.5M
+8.74%
-17.0M
+135.84%
-7.2M
N/A
Total Stockholders Equity
-1.4M
+20.03%
-1.2M
+64.58%
-725,821
+10.10%
-659,222
N/A
Total Shares Outstanding
996.1M
+37.90%
722.3M
+65.59%
436.2M
0.00%
436.2M
N/A
Cash Flow
Cash from Operating Activities
-205,760
-37.08%
-326,995
-56.47%
-751,232
+213.36%
-239,735
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
1,782
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
-1,782
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
199,395
-39.10%
327,400
-51.55%
675,750
+203.71%
222,500
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
-48,837.66%
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
-394,377.92%
N/A
Return on Assets
N/A
N/A
-18,744.06%
-8.33%
-20,447.32%
+4,280.15%
-466.82%
N/A
Return on Equity
148.32%
-4.28%
154.95%
-89.05%
1,415.35%
+1,656.56%
80.58%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
-81.88%
N/A
Current Ratio
0.00
-100.00%
0.008
+1.23%
0.008
-93.15%
0.12
N/A
Cash Ratio
0.00
-100.00%
0.005
-34.57%
0.008
-92.55%
0.11
N/A
Debt-to-Equity Ratio
-0.34
+29.05%
-0.26
+95.33%
-0.13
-82.21%
-0.76
N/A
Debt-to-Assets Ratio
N/A
N/A
31.77
+93.21%
16.44
+195.59%
5.56
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow